CAM
BLUE

Connacht Asset Management’s bluebird bio BLUE Stock Holding History

Connacht Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$96.2K Buy
+1,582
New +$111K 0.57% 47

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Connacht Asset Management's BLUE Position: Q3 2023 in Review

Connacht Asset Management opened a new position in bluebird bio (BLUE) in Q3 2023: 1,582 shares worth $96.2K. The stake represents 0.57% of the portfolio and ranks #47 among its holdings.

168 funds tracked by Wall St. Rank hold BLUE as of Q3 2023.

  • Connacht Asset Management held 1,582 shares of bluebird bio worth $96.2K as of Q3 2023.
  • bluebird bio was a new Connacht Asset Management position in Q3 2023.
  • bluebird bio made up 0.57% of Connacht Asset Management's portfolio in Q3 2023, its #47 holding.
  • 168 funds tracked by Wall St. Rank held bluebird bio as of Q3 2023.

Based on Connacht Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.